The hydrophobic temperature dependence of amino acids directly calculated from protein structures E van Dijk, A Hoogeveen, S Abeln PLoS Comput Biol 11 (5), e1004277, 2015 | 149 | 2015 |
Spatiotemporal regulation of clonogenicity in colorectal cancer xenografts M van der Heijden, DM Miedema, B Waclaw, VL Veenstra, MC Lecca, ... Proceedings of the National Academy of Sciences 116 (13), 6140-6145, 2019 | 64 | 2019 |
Chromosomal copy number heterogeneity predicts survival rates across cancers E van Dijk, T Van Den Bosch, KJ Lenos, K El Makrini, LE Nijman, ... Nature communications 12 (1), 3188, 2021 | 56 | 2021 |
Coarse-grained vs. atomistic simulations: realistic interaction free energies for real proteins A May, R Pool, E van Dijk, J Bijlard, S Abeln, J Heringa, KA Feenstra Bioinformatics, btt675, 2013 | 55 | 2013 |
The hydrophobic effect characterises the thermodynamic signature of amyloid fibril growth JHM Van Gils, E Van Dijk, A Peduzzo, A Hofmann, N Vettore, ... PLoS computational biology 16 (5), e1007767, 2020 | 42 | 2020 |
Consistent treatment of hydrophobicity in protein lattice models accounts for cold denaturation E Van Dijk, P Varilly, TPJ Knowles, D Frenkel, S Abeln Physical review letters 116 (7), 078101, 2016 | 41 | 2016 |
Chromosome 20 loss is characteristic of breast implant–associated anaplastic large cell lymphoma GT Los-de Vries, M De Boer, E van Dijk, P Stathi, NJ Hijmering, ... Blood, The Journal of the American Society of Hematology 136 (25), 2927-2932, 2020 | 40 | 2020 |
Molecular characterization of colorectal cancer related peritoneal metastatic disease KJ Lenos, S Bach, L Ferreira Moreno, S Ten Hoorn, NR Sluiter, ... Nature communications 13 (1), 4443, 2022 | 39 | 2022 |
Computational screening of tip and stalk cell behavior proposes a role for apelin signaling in sprout progression MM Palm, MG Dallinga, E van Dijk, I Klaassen, RO Schlingemann, ... PloS one 11 (11), e0159478, 2016 | 39* | 2016 |
Loss of chromosome 18q11. 2-q12. 1 is predictive for survival in patients with metastatic colorectal cancer treated with bevacizumab E Van Dijk, HD Biesma, M Cordes, D Smeets, M Neerincx, S Das, PP Eijk, ... Journal of Clinical Oncology 36 (20), 2052-2060, 2018 | 34 | 2018 |
Extracellular vesicle miRNA predict FDG‐PET status in patients with classical Hodgkin Lymphoma EEE Drees, MGM Roemer, NJ Groenewegen, J Perez‐Boza, ... Journal of extracellular vesicles 10 (9), e12121, 2021 | 24 | 2021 |
The characteristics of molten globule states and folding pathways strongly depend on the sequence of a protein MJJ Dijkstra, WJ Fokkink, J Heringa, E van Dijk, S Abeln Molecular Physics 116 (21-22), 3173-3180, 2018 | 20 | 2018 |
Circulating tumor DNA analysis of EGFR-mutant non-small cell lung cancer patients receiving osimertinib following previous tyrosine kinase inhibitor treatment JJ Beagan, S Bach, RA van Boerdonk, E van Dijk, E Thunnissen, ... Lung Cancer 145, 173-180, 2020 | 18 | 2020 |
Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV GT Los-de Vries, WBC Stevens, E van Dijk, C Langois-Jacques, AJ Clear, ... Blood advances 6 (18), 5482-5493, 2022 | 16 | 2022 |
How sticky are our proteins? Quantifying hydrophobicity of the human proteome JHM van Gils, D Gogishvili, J van Eck, R Bouwmeester, E van Dijk, ... Bioinformatics advances 2 (1), vbac002, 2022 | 9 | 2022 |
PCR-free shallow whole genome sequencing for chromosomal copy number detection from plasma of cancer patients is an efficient alternative to the conventional PCR-based approach JJ Beagan, EEE Drees, P Stathi, PP Eijk, L Meulenbroeks, F Kessler, ... The Journal of Molecular Diagnostics 23 (11), 1553-1563, 2021 | 9 | 2021 |
A bioinformatics perspective on molecular classification of diffuse large B-cell lymphoma M Mendeville, J Janssen, Y Kim, E van Dijk, D de Jong, B Ylstra Leukemia 36 (9), 2177-2179, 2022 | 6 | 2022 |
A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT) CI Stroes, S Schokker, M Khurshed, SO van der Woude, RAA Mathôt, ... Therapeutic advances in medical oncology 14, 17588359221109196, 2022 | 3 | 2022 |
SPECIFIC GENETIC ALTERATIONS CHARACTERIZE SEROMA‐AND TUMOR‐TYPE BREAST‐IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA (BIA‐ALCL) AS A DISTINCT DISEASE ENTITY B Ylstra, GT Los‐de Vries, M de Boer, E van Dijk, P Stathi, N Hijmering, ... Hematological Oncology 37, 201-202, 2019 | 2 | 2019 |
Long-term Survival Update and Extended RAS Mutational Analysis of the CAIRO2 Trial: Addition of Cetuximab to CAPOX/Bevacizumab in Metastatic Colorectal Cancer S Ten Hoorn, L Mol, DW Sommeijer, L Nijman, T van den Bosch, ... Clinical Colorectal Cancer 22 (1), 67-75, 2023 | 1 | 2023 |